Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.870
-0.170 (-3.37%)
At close: Aug 26, 2026, 4:00 PM EDT
4.950
+0.080 (1.64%)
Pre-market: Aug 27, 2026, 8:22 AM EDT

Coya Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8.027.953.556--
Revenue Growth
1793.76%123.57%-40.79%---
Gross Profit
-8.72-8.79-8.310.5-4.41-
Operating Income
-20.85-20.27-17.22-7.36-9.29-4.87
Net Income
-21.67-21.23-14.88-7.99-12.24-4.89
Earnings Per Share
-1.09-1.27-0.98-0.79-4.73-1.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
43.1846.8238.3432.635.934.34
Total Debt
----12.97-
Net Cash (Debt)
43.1846.8238.3432.63-7.034.34
Net Cash Growth
45.11%22.13%17.51%---50.23%
Net Cash Per Share
2.172.802.523.21-2.711.68

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.72-10.74-10.29-11.19-7.24-3.9
Capital Expenditures
------0.14
Free Cash Flow
-15.72-10.74-10.29-11.19-7.24-4.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-108.68%-110.61%-233.86%8.34%--
Operating Margin
-260.00%-255.05%-484.65%-122.62%--
Pretax Margin
-270.19%-267.10%-438.96%-121.02%--
Profit Margin
-270.22%-267.14%-418.70%-133.08%--
FCF Margin
-196.06%-135.16%-289.50%-186.41%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.2515.2726.9417.78--